In vitro and in vivo models for assessing drug efflux transporter activity
- 1 January 2003
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 55 (1), 31-51
- https://doi.org/10.1016/s0169-409x(02)00170-9
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Loss of ATP-dependent Transport Activity in Pseudoxanthoma Elasticum-associated Mutants of Human ABCC6 (MRP6)Journal of Biological Chemistry, 2002
- Comparative Studies on in Vitro Methods for Evaluating in Vivo Function of MDR1 P-GlycoproteinPharmaceutical Research, 2001
- Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interactionEuropean Journal of Pharmaceutical Sciences, 2000
- Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogsProceedings of the National Academy of Sciences, 2000
- Kinetic and biochemical analysis of carrier-mediated efflux of drugs through the blood–brain and blood–cerebrospinal fluid barriers: importance in the drug delivery to the brainJournal of Controlled Release, 1999
- Using the National Cancer Institute Anticancer Drug Screen to Assess the Effect ofMRPExpression on Drug Sensitivity ProfilesPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,1998
- P-Glycoprotein Substrates and Antagonists Cluster into Two Distinct GroupsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,1997
- The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell linesCancer Letters, 1996
- Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells.JCI Insight, 1996
- Characterization of the ATP‐dependent leukotriene C4 export carrier in mastocytoma cellsEuropean Journal of Biochemistry, 1994